NAVAMEDIC ASA NK 1
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more
Market Cap & Net Worth: NAVAMEDIC ASA NK 1 (N1A)
NAVAMEDIC ASA NK 1 (F:N1A) has a market capitalization of $44.80 Million (€43.65 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #23719 globally and #2591 in its home market, demonstrating a 2.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NAVAMEDIC ASA NK 1's stock price €1.82 by its total outstanding shares 23981378 (23.98 Million).
NAVAMEDIC ASA NK 1 Market Cap History: 2019 to 2026
NAVAMEDIC ASA NK 1's market capitalization history from 2019 to 2026. Data shows growth from $45.42 Million to $44.80 Million (8.81% CAGR).
NAVAMEDIC ASA NK 1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NAVAMEDIC ASA NK 1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of N1A by Market Capitalization
Companies near NAVAMEDIC ASA NK 1 in the global market cap rankings as of March 18, 2026.
Key companies related to NAVAMEDIC ASA NK 1 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
NAVAMEDIC ASA NK 1 Historical Marketcap From 2019 to 2026
Between 2019 and today, NAVAMEDIC ASA NK 1's market cap moved from $45.42 Million to $ 44.80 Million, with a yearly change of 8.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €44.80 Million | +0.55% |
| 2025 | €44.56 Million | -14.62% |
| 2024 | €52.19 Million | -34.77% |
| 2023 | €80.00 Million | +0.31% |
| 2022 | €79.76 Million | +6.23% |
| 2021 | €75.08 Million | +69.92% |
| 2020 | €44.19 Million | -2.71% |
| 2019 | €45.42 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NAVAMEDIC ASA NK 1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $44.80 Million USD |
| MoneyControl | $44.80 Million USD |
| MarketWatch | $44.80 Million USD |
| marketcap.company | $44.80 Million USD |
| Reuters | $44.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.